Senators grill industry groups over FDA user fee agreements to fund the agency through 2027
Members of the Senate health committee on Tuesday fired off questions at drug industry reps in the first of two hearings to deal with the latest five-year funding agreements that Congress has to re-authorize by the end of September and that the FDA relies on to review new drug, generic drug, biologic and biosimilar applications. … Continue reading Senators grill industry groups over FDA user fee agreements to fund the agency through 2027
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed